Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours.

about

Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades.

P2860

Q38610456-446C63C3-3A98-4428-A5E3-FC16312678CE

P2860

Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours.

Item

http://www.wikidata.org/entity/Q38757792

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Predicting risk factors for ra ...... ry or metastatic lung tumours.

@en

type

Item

label

Predicting risk factors for ra ...... ry or metastatic lung tumours.

@en

prefLabel

Predicting risk factors for ra ...... ry or metastatic lung tumours.

@en

P1476

Predicting risk factors for ra ...... ry or metastatic lung tumours.

@en

P2093

Akira Sakurada

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Koizumi

http://www.w3.org/2001/XMLSchema#string

Koichi Tokuuye

http://www.w3.org/2001/XMLSchema#string

Mitsuru Okubo

http://www.w3.org/2001/XMLSchema#string

Ryuji Mikami

http://www.w3.org/2001/XMLSchema#string

Sachika Shiraishi

http://www.w3.org/2001/XMLSchema#string

Shinji Sugahara

http://www.w3.org/2001/XMLSchema#string

Tatsuhiko Saito

http://www.w3.org/2001/XMLSchema#string

P2860

A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data.

Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis.

Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy

Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury.

Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers.

Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors.

Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.

Patients with severe emphysema have a low risk of radiation pneumonitis following stereotactic body radiotherapy.

P304

20160508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1259/BJR.20160508

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1073

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hidetsugu Nakayama

T Itonaga

P577

2017-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28195507

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5605097

http://www.w3.org/2001/XMLSchema#string

Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours.

about

P2860

P2860

Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932